Question 1

Which Wall Street gurus hold Tango Therapeutics Inc (TNGX)?

Accepted Answer

Per the latest SEC 13F filings, 15 Wall Street gurus hold TNGX. Top holders include 조셉 에델만, 드미트리 발야스니, 스티브 코헨, with a combined position value of about $744.1M.

Question 2

What sector does Tango Therapeutics Inc belong to?

Accepted Answer

Tango Therapeutics Inc (TNGX) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Tango Therapeutics Inc?

Accepted Answer

Key metrics for Tango Therapeutics Inc (TNGX): EPS $-0.83, Beta 1.12. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Joseph Edelman Perceptive Advisors LLC	0.33%	808,153	$16.91M	HOLD
2	Dmitry Balyasny Balyasny Asset Management LP	0.11%	3,826,659	$80.05M	HOLD
3	Steve Cohen Point72 Asset Management LP	0.01%	533,937	$11.17M	HOLD
4	Goldman Sachs Goldman Sachs Asset Management	0.01%	5,076,392	$106.20M	HOLD
5	Fidelity (FMR) Fidelity Management & Research	0.01%	9,905,919	$207.23M	HOLD
6	Israel Englander Millennium Management LLC	0.00%	425,644	$8.90M	HOLD
7	State Street State Street Global Advisors	0.00%	4,651,894	$97.32M	HOLD
8	BlackRock BlackRock Inc	0.00%	8,748,045	$183.01M	HOLD
9	Two Sigma Two Sigma Investments LP	0.00%	173,132	$3.62M	HOLD
10	T. Rowe Price T. Rowe Price Associates	0.00%	889,400	$18.61M	HOLD
11	Joel Greenblatt Gotham Asset Management LLC	0.00%	19,137	$400,346	HOLD
12	Ken Fisher Fisher Asset Management LLC	0.00%	162,399	$3.40M	HOLD
13	Cliff Asness AQR Capital Management LLC	0.00%	107,286	$2.24M	HOLD
14	Ken Griffin Citadel Advisors LLC	0.00%	179,423	$3.75M	HOLD
15	JPMorgan Chase JPMorgan Asset Management	0.00%	67,326	$1.29M	HOLD

Insider	Title	Type	Shares	Value	Date
Crystal Adam	President, R&D	SELL	7,371	$0.2M	7/1/2026
Crystal Adam	President, R&D	SELL	27,000	$0.1M	7/1/2026
Crystal Adam	President, R&D	SELL	19,629	$0.6M	7/1/2026
Azelby Robert	Director	BUY	35,910	$1.0M	6/19/2026
Azelby Robert	Director	BUY	5,740	--	6/19/2026
Crystal Adam	President, R&D	SELL	27,000	$0.1M	5/1/2026
Crystal Adam	President, R&D	SELL	1,100	$0.0M	5/1/2026
Crystal Adam	President, R&D	SELL	25,900	$0.5M	5/1/2026

Tango Therapeutics Inc

Holders (15)

Insider Trades (8)